Perlin Lab
David S. Perlin, Ph.D.
Chief Scientific Officer
Executive Vice President
Hackensack Meridian Health Center for Discovery and Innovation
Professor, Hackensack Meridian School of Medicine
Professor, Georgetown University School of Medicine
Fellow, New York Academy of Sciences
Fellow, American Academy of Microbiology
Dr. David S. Perlin is a highly accomplished biomedical researcher and chief executive who is well recognized for his innovative and entrepreneurial leadership in the biomedical sciences. He is the inaugural Chief Scientific Officer and EVP for the Hackensack Meridian Center for Discovery and Innovation (CDI), which seeks to rapidly translate innovations in science to improve outcomes for patients with cancer, infectious diseases, autoimmune, and other acute and chronic disorders.
Under his leadership, CDI has grown in less than five years to 32 laboratories with more than 200 scientists and support staff funded by 126 grants and contracts including 60 NIH grants. Dr. Perlin has been engaged for more than 30 years in developing molecular insights and technologies to detect, combat and prevent deadly infections. He is an expert in drug discovery and drug resistance mechanisms, and he has helped develop novel therapeutics and diagnostics against high-threat bacteria, viruses, and fungi. He has published more than 360 papers and book chapters and has co-authored two books, and his laboratory is supported by multiple grants from the NIH, Pharma and biopharma sectors, and the NIH has continuously funded him for 30+ years. He has served on numerous advisory boards for Pharma and Biotech to develop FDA approved drugs. Currently, he leads an NIH-designated national Center of Excellence in Translational Research (CETR) to discover novel anti-infectives against drug resistant bacterial infections. He also co-leads with Rockefeller University Nobel Laureate Dr. Charles Rice the Metropolitan Antiviral Drug Accelerator (MAVDA), one of nine national centers under the NIH AViDD program to develop novel small molecule antiviral drugs against SARS-CoV-2 and other pandemic viruses.
Recent Honors and Awards
Medical Technology Pioneer Health Care Heroes Award for COVID-19 response
Fellow of the American Academy of Microbiology
Fellow of the New York Academy of Sciences
Named by RO1 as a Top 10 Influencer in Healthcare in New Jersey (2019, 2020)
Outstanding Scientist in New Jersey by the Edward J. Ill Excellence in Medicine Awards (2020, 2021, 2021)
Top 25 National Innovator by Modern Healthcare (2021)
Named a Top 25 Notable Health Care Leader by Crain’s New York Business (2022)
Dr. Sol J. Barer Award for Vision, Innovation, and Leadership (2023)
Named by ROI as a Top 25 Healthcare Influencer (2024)